Catecholamines due to various mechanisms may contribute to the accumulation of collagen fibers and extracellular matrix in the arterial wall. The aim of this study was to compare intima-media thickness (IMT) of the common carotid artery (CCA) and carotid bifurcation (CB) in patients with pheochromocytoma, essential hypertension and healthy controls. Carotid ultrasound studies were carried out in 30 patients with pheochromocytoma matched for age and gender with 80 patients with essential hypertension and 40 normotensive controls. Significantly higher IMT was found in patients with pheochromocytoma and essential hypertension compared to controls when measured in the CCA (0.931 ± 0.223, 0.825±0.146 and 0.738±0.113 mm; Po0.001; Po0.05), and only in patients with pheochromocytoma compared to controls in the region of CB (1.359 ± 0.593, 1.095 ± 0.311 and 0.968 ± 0.247 mm; Po0.001; P ¼ 0.13). Higher IMT in patients with pheochromocytoma compared to patients with essential hypertension was also statistically significant in both carotid regions (both Po0.01). This difference remained significant after adjustment for all relevant clinical and biochemical covariates in the CCA (P ¼ 0.014) but disappeared in the region of CB (P ¼ 0.079). In summary, patients with pheochromocytoma have increased common carotid IMT when compared to patients with essential hypertension. This finding could be caused by the deleterious effects of the excess of catecholamines on the vascular wall growth and thickening.
Introduction
Pheochromocytomas/functional paragangliomas are tumours arising from chromaffin cells either from the adrenal medulla (pheochromocytoma) or from the sympathetic nervous system-associated chromaffin tissue (functional paraganglioma), which possess the ability to produce, metabolize and secrete catecholamines. [1] [2] [3] Catecholamines produced by the tumour cells are responsible for the large variety of symptoms and signs, including their effect on hemodynamics or metabolism. 4 In vitro 5 and in vivo 6, 7 studies showed that catecholamines influence vascular wall growth and remodelling, independently of their hemodynamic impact. This direct action of catecholamines on the vascular bed 5, 8, 9 through extracellular matrix protein activity with protein synthesis and collagen deposition may consequently lead to the vascular eutrophic remodelling. 10 On the contrary, in experimental vascular injury, 5 this process involves proliferation, hypertrophy and migration of smooth muscle cells and adventitial fibroblasts, leading to hypertrophic remodelling.
Limited data regarding the effects of chronic catecholamine overproduction on the vasculature are available in humans. Activation of the adrenergic system may play a relevant role in the development of eutrophic remodelling in small vessels, 11 whereas both eutrophic and hypertrophic remodelling may occur in large arteries. Ultrasound examination of large vessels can identify hypertrophic remodelling of large arteries as arterial wall thickening. One of the previous studies did not find differences in arterial wall thickness in three carotid segments among patients with pheochromocytoma, primary aldosteronism and essential hypertension. 12 Another study found borderline increased wall thickness of the common carotid artery (CCA) in patients with pheochromocytoma when compared with patients with newly diagnosed essential hypertension. 13 None of the studies, however, examined the arterial wall changes using the mean of maximum (mean-max) intima-media thickness (IMT) measurement in exactly predefined scanning angles together with left-ventricular echocardiographic parameters and 24-h blood pressure (BP) monitoring in a relatively large group of patients suffering from catecholamine overproduction.
Our prospective study was aimed at investigating the hypothesis that structural alterations of the carotid arteries characterized by increased IMT in two distal segments of the right and left CCA and carotid bifurcation (CB) are more advanced in patients with pheochromocytoma than in patients with essential hypertension.
Methods

Study population
The patients with pheochromocytoma were recruited from patients hospitalized at our tertiary Centre for Arterial Hypertension between November 2003 and June 2008 prospectively; essential hypertensive patients were matched for age, gender and 24-h systolic BP. Each participant provided his/her written informed consent, and the study protocol was approved by the local ethics committee.
Thirty patients with pheochromocytoma, aged 30-78 years (15 men and 15 women), were enrolled into the study. The diagnosis of pheochromocytoma was based on elevated 24-h urine catecholamines (13 subjects with elevated norepinephrine and epinephrine above the upper reference limit, 15 subjects with elevated norepinephrine and 2 subjects with elevated epinephrine) and positive finding on computed tomography or magnetic resonance imaging. All subjects underwent surgical removal of the tumour and the diagnosis was confirmed histopathologically. Sixteen patients with pheochromocytoma had diabetes.
Total of 80 essential hypertensive patients (40 men and 40 women) were enrolled when main forms of secondary hypertension (primary aldosteronism, pheochromocytoma, Cushing's syndrome, renal parenchymal disease, renovascular hypertension) or drug-induced hypertension were excluded. Subjects were considered hypertensive, if their clinic BP (average of three different sphygmomanometric measurements each performed on three separate days, after a washout period of at least 2 weeks if previously treated with antihypertensive drugs) was X140/90 mm Hg.
14 Chronic antihypertensive therapy was discontinued at least 2 weeks before admission and patients were switched to the treatment with a-blocker and/or slow release verapamil.
Forty controls (20 men and 20 women) were recruited from subjects without a history of hypertension or cardiovascular disease and free of antihypertensive medication, which were referred for carotid ultrasound because of other risk factors for atherosclerosis. Controls were considered normotensive if their BP was o140/90 mm Hg.
Current smokers were defined as those who smoked X1 cigarette per day or those who quit smoking less than 1 year ago. Diabetes mellitus was defined as the medication with oral antidiabetic drugs or repeated fasting glucose levels 47.0 mmol l
À1
. 15 Insulin-dependent diabetic patients were excluded from the study. All subjects with dyslipidaemia (total plasma cholesterol X5.0 mmol l À1 or low-density cholesterol X3.0 mmol l À1 or high-density lipoprotein cholesterol p1.0 mmol l À1 in men and p1.2 mmol l À1 in women or triglycerides X1.7 mmol l À1 ) were on diet and received lipid-lowering therapy. 16 Patients after carotid endarterectomy, percutaneous carotid intervention and poor quality of carotid arteries visualization by ultrasound were excluded.
BP monitoring
Blood pressure at office was measured in the sitting position by using a standard sphygmomanometer, while the participant underwent the ultrasound examination. In hypertensive patients, the latest BP values before discontinuation of their usual antihypertensive therapy were also recorded. Twenty-four hour ambulatory BP monitoring was performed using oscillometric device (SpaceLabs 90207 Medical, Richmond, WA, USA), which was set to measure BP every 20 min during the day (from 0600 to 2200 h) and every 30 min during the night (from 2200 to 0600 h). Both groups of hypertensive patients were matched for 24-h BP.
Laboratory
Urine catecholamines were analysed by high performance liquid chromatography with fluorometric detector (HPLC/FLD 1100S, Agilent Technologies, Santa Clara, CA, USA). The system was calibrated with a catecholamine standard using the ClinRep test kit (Recipe Chemicals and Instruments GmbH, Munich, Germany).
Blood biochemistry (sodium, potassium, urea, creatinine, total, low-density lipoprotein, high-density lipoprotein cholesterol, triglycerides and glycemia) was analysed using multi-analyzers (Modular; Roche Diagnostics, Basel, Switzerland) in the institutional central laboratory.
Echocardiography M-mode, two-dimensional and Doppler echocardiography (Philips SONOS 5500, Andover, MA, USA) was performed according to a standard protocol. M-mode images of the left ventricle at the mitral valve tip were obtained, guided by a two-dimensional parasternal short-axis or long-axis view, with the subjects lying down in the left lateral decubitus position, at end-expiration. The left-ventricular Increased carotid intima-media thickness in pheochromocytomaend-diastolic dimension (LVDd), interventricular septal thickness (IVST) and posterior wall thickness (PWT) were measured at the end of diastole according to the Penn Convention. 17 Relative wall thickness was calculated as 2 Â (PWT/LVDd). 18 To estimate the left-ventricular mass (LVM), following formula of Devereux and Reichek was used:
3 )-13.6. The left-ventricular mass index was calculated for each patient by dividing LVM by body surface area. 19 Carotid ultrasound and IMT measurement High-resolution B-mode carotid ultrasound was performed with multi-frequency (5-10 MHz) linear array transducer (Acuson Sequoia 512, Siemens Medical Solutions, Mountain View, CA, USA). Standardized longitudinal B-mode images of the far wall were obtained proximally from the tip of the flow divider (zero reference point). Carotid segments (CB and CCA) were defined between 0 and 10 mm and between 10 and 20 mm from this reference point, respectively. Using Meijer's Carotid Arc (Meyer Medical Ultrasound, Utrecht, The Netherlands), images were taken at two angles of 90 and 150 degrees for the right carotid artery, and 210 and 270 degrees for the left carotid artery. 20 When an optimal image was obtained, it was frozen on the top of the R-wave of QRS complex, saved in DICOM format and written to 640 MB magnetic optical disc.
The IMT measurements were performed off-line. Frozen images were displayed on the screen of a computer using an automated edge detection program Image Pro-Plus version 4.0 (Media Cybernetics, Silver Spring, MD, USA). In each image, the visualized blood-intima and media-adventitia boundaries (including presented plaques) of the far wall were marked with a computer mouse-controlled caliper within the defined segment. 21 The largest distance between these two lines was considered representative IMT for each segment. The average of four IMT measurements-the mean of maximum (mean-max) IMT (2 angles, 2 sides)-was calculated for CCA and CB segments (CCA IMT, CB IMT). Combined IMT per patient was calculated as average of CCA IMT and CB IMT. This approach including IMT reproducibility was described in detail elsewhere. 20 Statistical analysis Data were analysed using STATISTICA version 6.1 (StatSoft, Tulsa, OK, USA). Depending on the normality/non-normality of distribution of particular variables, results were given as mean±s.d. or median (interquartile range). Multiple-group comparisons were performed by one-way analysis of variance, followed by the Scheffe's multiple range test. Differences between both hypertensive groups were analysed using unpaired t-test or KruskalWallis test for normally or non-normally distributed variables, respectively. A w 2 test was used for categorical data. Multivariate linear regression models were used when appropriate to correct for the differences in clinical and biochemical characteristics. Relationship between continuous variables was assessed by Pearson's correlation analysis. P-value o0.05 was considered significant.
Results
Clinical characteristics and biochemical data
The three groups of subjects did not differ by age, gender, height, total cholesterol, low-density lipoprotein cholesterol and triglycerides (Table 1) . Patients with essential hypertension had higher body weight (Po0.05) and body mass index (Po0.01) than patients in the other groups. Controls had higher high-density lipoprotein cholesterol than patients with essential hypertension (Po0.05). More diabetic patients were found in the pheochromocytoma group than in the others (Po0.001), so that patients with pheochromocytoma had significantly higher fasting blood glucose than patients in other groups (Po0.001). Urinary catecholamines were significantly higher in patients with pheochromocytoma than in essential hypertensive patients, and the difference was more prominent for norepinephrine (Po0.001) rather than for epinephrine (Po0.001), whereas only borderline for dopamine (Po0.05).
BP data
Systolic and diastolic BP measured at office was expectedly higher in groups of hypertensive patients on their chronic antihypertensive therapy than in normotensive subjects. Patients with essential hypertension presented with significantly higher systolic BP measured at office (Po0.001) when compared to patients with pheochromocytoma but no differences were found in diastolic BP measured at office (Table 1) . After discontinuation of chronic antihypertensive therapy and switching to the treatment with a-blocker and/or slow release verapamil, the BP values in essential hypertensive patients increased, so that differences in systolic and diastolic BP values between both hypertensive groups deepened and achieved statistical significance not only for systolic BP (Po0.001), but also for diastolic BP (Po0.01). However, differences between both hypertensive groups in 24-h systolic and diastolic BP remained nonsignificant (Table 2) .
Medical treatment
Patients with essential hypertension had longer estimated duration of hypertension and dyslipidaemia (Po0.05) and were treated with significantly higher number of antihypertensive drugs (Po0.001)
Increased carotid intima-media thickness in pheochromocytomathan patients with pheochromocytoma. Significantly higher percentage of essential hypertensive patients was treated by calcium channel blockers, angiotenzin-converting enzyme inhibitors and central agonists (Po0.01), diuretics and statins (Po0.05). On the other hand, more patients with Increased carotid intima-media thickness in pheochromocytoma R Holaj et al pheochromocytoma were on oral antidiabetic drugs (Po0.05; Table 2 ).
Echocardiographic data
In pheochromocytoma and essential hypertensive patients, an increased left-ventricular mass index, relative wall thickness, PWT and IVST was observed compared to controls, but no difference was found between pheochromocytoma and essential hypertensive patients (Table 3) . Table 3 shows that all carotid IMT parameters (CCA IMT, CB IMT and combined IMT) in patients with pheochromocytoma were not only higher than those in control normotensive subjects (Po0.001), but also higher than those in patients with essential hypertension (Po0.01). IMT parameters in essential hypertensive patients were significantly higher than those in control normotensive subjects when measured in the segment of the CCA (Po0.05) and in the segments of the CCA and CB combined (Po0.05), whereas no difference was found in the CB segment (P ¼ 0.13).
Carotid IMT
Covariates of IMT
Correlations between IMT measurement and clinical characteristics and biochemical data are shown in Table 4 . Except a well-known association between IMT and age, only total and low-density lipoprotein cholesterol correlated with IMT in the CB region in patients with pheochromocytoma. In patients with essential hypertension, number of antihypertensive drugs, systolic BP measured at office and 24-h Increased carotid intima-media thickness in pheochromocytomasystolic BP and fasting plasma glucose weakly correlated with CB IMT.
IMT in multivariate model
To assess independent difference in IMT between patients with pheochromocytoma and essential hypertension, three multivariate models were tested separately for CCA IMT, CB IMT and combined IMT. Into each of them clinical/biochemical variables entered if they significantly differed between groups or if they significantly correlated with particular IMT variable in one or both groups of patients. Multivariate correlation coefficients for all relevant covariates are shown in Table 5 . Intima-media thickness differences between patients with pheochromocytoma and essential hypertension disappeared for CB region, whereas remained significant for CCA and combined IMT. When between-group differences in antihypertensive, oral antidiabetic and lipid-lowering therapy were added into the models, the results did not notably changed (not shown).
Discussion
We showed that patients with pheochromocytoma have significantly increased IMT of the distal segment of the CCA not only in comparison with normotensive controls but also in comparison with essential hypertensive patients even after adjustment for all relevant confounders. This indicates that the arterial wall damage in patients with pheochromocytoma is more profound than in essential hypertension likely due to excessive catecholamine production.
There are direct and indirect mechanisms that may explain the increase of carotid IMT in subjects with pheochromocytoma. Previous in vitro studies have found that norepinephrine leads to hypertrophy and proliferation of cultured smooth muscle cells 10 and also induces proliferation of adventitial fibroblasts. 8 Norepinephrine-induced hypertrophy of the vascular smooth muscle cells is mediated by a-adrenoceptors, in particular by a 1A,1B and a 1D adrenoceptors. 8 a 1 Adrenoceptors of the smooth muscle cells stimulate production of transforming growth factors b-1, which is involved in vascular hypertrophy, collagen and fibronectin expression. 10, 22 Another mechanism, which can lead to the more pronounced thickening of carotid intima-media in subjects with pheochromocytoma, is subclinical inflammation. In our earlier study, we showed an increase of inflammatory markers in subjects with pheochromocytoma compared with patients with other forms of hypertension and normotensive controls, which was reversed by tumour removal. 23 Subclinical inflammation has been shown to correlate positively with IMT. [24] [25] [26] Finally, catecholamine overproduction in pheochromocytoma in often associated with exaggerated BP variability. 27 Higher 24-h systolic BP variability was proven as another possible risk factor leading to increased carotid intima-media thickening. 28 All these mechanisms may explain higher IMT in subjects with pheochromocytoma compared to subjects with essential hypertension, whereas no differences were found in parameters of the leftventricular geometry, which are primarily BP dependent. No differences in echocardiographic parameters were also found in the earlier studies in patients with pheochromocytoma compared to essential hypertensive patients. 11, 29 Lack of correlation between BP variables (both BP measured at office and 24-h BP) and IMT in our group of patients with pheochromocytoma suggests that vascular changes in patients with catecholamine overproduction are not BP dependent.
To our knowledge the largest study investigating changes in the cardiac and vascular structure in patients with primary and secondary hypertension including patients with pheochromocytoma was published by Rizzoni et al. 12 The authors found the trend to the higher IMT values in patients with pheochromocytoma compared to essential hypertensive patients. It might be speculated that higher Increased carotid intima-media thickness in pheochromocytoma R Holaj et al number of subjects with pheochromocytoma in their study (n ¼ 11) could have revealed statistically significant difference. In the recent ultrasound study, Bernini et al. found in 15 patients with pheochromocytoma that IMT in distal CCA segment was almost significantly higher (P ¼ 0.06) than that in 15 BP-matched mild hypertensive patients. However, only BP measured at office were used for BP-matching in this study (not 24-h ambulatory BP recordings as in our study); therefore, it could not be definitely excluded that their results were, at least in part, attributable to potential between-group differences in global BP burden. Even more statistically significant results were found for ultrasonic integrated backscatter signal recorded from the distal segment of CCA. 13 In pheochromocytoma group, the value of this signal positively correlated with urinary norepinephrine, however, as well as in our study, no correlation between IMT and various catecholamine urinary concentrations was observed.
At least four explanations may be offered for missing relationship between IMT and catecholamines. Because carotid IMT is significantly agedependent, age heterogeneity in our patients may mask the relationship between IMT and other factors, including catecholamines. Second, catecholamine levels may not necessarily reflect their tissue effect. Third, catecholamines excretion may have day-to-day variation. Fourth, 'dose-dependent' effect of catecholamines on IMT progression may be nonlinear and already saturated in the range of catecholamine levels observed in pheochromocytoma patients. Indeed, weak but significant correlation was found between IMT and normal-ranged urinary norepinephrine values in essential hypertensive patients (Table 4) .
Some observations in our study deserve additional comments. First, longer duration of hypertension implies that our patients with pheochromocytoma should have a catecholamine producing tumour for a longer time than in other studies. 30 Majority of patients with pheochromocytoma were referred to our tertiary centre from other centres and therefore we can not precisely evaluate the onset of the disease.
Second, prevalence of diabetes in patients with pheochromocytoma found in this as well as in our earlier study 27 was higher (53 and 54%, respectively) than that in the studies published by other authors (34 and 43%, respectively). 30, 31 Besides longer disease duration, it may be in a consequence of different patient's phenotype. More patients with pheochromocytoma in our study had an epinephrine-producing tumour compared to other studies. Third, correlation between total and lowdensity lipoprotein cholesterol and CB IMT was found only in patients with pheochromocytoma. Lack of such correlation in essential hypertensive patients could be explained by relatively high percentage of these patients taking lipid-lowering drugs (30%), namely statins (20%), interfering with this relationship.
In contrast to studies mentioned above, we employed different approach for IMT measurement. We chose mean-max carotid IMT assessment which was reported to be superior to the method of mean carotid IMT assessment. 32 Nevertheless we did not measure the IMT in proximal segment of the internal carotid arteries. The optimal approach for IMT measurement is still debated, 33 but some other authors recommend IMT measurement only on the far wall in distal segment of the CCA and in the region CB as we have used. 34 We did not focus this study to evaluate the prevalence of carotid plaques. Although, ultrasound definition of atherosclerotic plaques was accepted by some experts, 35 to our opinion, ambiguous differences between 'small plaque' and 'local intima thickening' could adversely influence the results. Also, correct quantification of atherosclerotic plaques in some patients with advanced atherosclerotic process in CB seems to be practically impossible. On the other hand, the presence of carotid plaques projects onto the mean-max IMT value, that is, this value encompasses the plaque involvement.
Although increase of IMT in CB region was more pronounced ( þ 26%) than that in CCA region ( þ 13%) in patients with pheochromocytoma in comparison with essential hypertensive patients, the level of statistical significance was comparable (P ¼ 0.003 and P ¼ 0.007, respectively). Moreover, the IMT differences in CB between both groups became nonsignificant when adjusted for clinical and biochemical covariates. Because reproducibility of IMT measurement in both regions was previously shown to be similar (intra-individual correlation coefficients for pairs of IMT measurements were 0.79 and 0.86 for CB and CCA, respectively), 20 it might be suggested that discordant results were caused by the higher biological variability of IMT in the region of CB with greater impact of atherogenic risk factors.
Limitations
We enrolled a relatively small number of patients with pheochromocytoma in comparison to relatively large population of patients with essential hypertension. This fact was caused by the relative rare incidence of pheochromocytoma among hypertensive patients.
Frequency of various antihypertensive drugs was not identical in both groups of hypertensive patients. The intervention studies in essential hypertensive patients found that therapy with calcium channel-blockers could have superior effect on the regression of carotid atherosclerosis than therapy with diuretics and b-blockers independently on BP lowering. [36] [37] [38] [39] Essential hypertensive patients in our study were on calcium channel blockers therapy in higher percentage of cases (73 vs Increased carotid intima-media thickness in pheochromocytoma R Holaj et al 40%, respectively). However, the presence of calcium channel blockers therapy (as well as other antihypertensive drugs) did not affect the IMT difference between patients with pheochromocytoma and essential hypertension in multivariate analysis. Therefore, we believe that between-group imbalance in medical therapy did not distort the results substantially. We also were not fully able to match the group of subjects with pheochromocytoma with the essential hypertension group. The overproduction of catecholamines leads not only to hypertension and weight loss but also to abnormalities in glucose metabolism. This makes the exact matching of both groups unachievable. Therefore, we cannot exclude the possible impact of diabetes on advanced IMT thickening in subjects with pheochromocytoma. On the other hand, essential hypertensive patients had definitely higher atherogenic risk profile, namely longer duration of hypertension, higher systolic BP at office and higher body mass index, which may counteract the IMT differences between both groups. Accordingly, adjustment for all these covariates did not abolish the significant IMT difference in CCA.
In summary, our study confirms previous suggestions that patients with pheochromocytoma have increased carotid IMT when compared to BPmatched essential hypertension patients even after the adjustment for incidental between-group differences. This finding could be because of the deleterious effects of catecholamines excess on the growth and thickening of the arterial wall and is presented mainly in CCA. IMT differences in CB became nonsignificant because of the higher biological variability of IMT in the CB region most likely due to greater impact of atherogenic risk factors.
